Frequently Asked Questions
How do I get started?
Call, text, or email our team to talk about your goals, eligibility for the medication, and any other questions you have. We will obtain a medical history, get you set up for a Telehealth visit with one of our providers, and could have the medication ordered and on the way as early as the same day.
Who is eligible for a prescription?
Adults over the age of 18 with a BMI over 25 may be eligible for a prescription. Contraindications include: history of MEN Type 2, history of medullary thyroid cancer, and pregnancy. Precautions include history of pancreatitis or gallstones, and taking any other medications for diabetes management.
What is the dosing schedule like?
Semaglutide is titrated up from 0.3mg for two weeks, to 0.4mg for two weeks, and finally to 0.54mg for the official “starting dose”. From there, you may increase the dose to 1.08mg, 2.16mg, and so on, until you find the lowest effective dose for you.
Tirzepatide requires no titration. Patients start at a 2.5mg dose. From there, doses increase to 5mg, 7.5mg, and so on, until you find the lowest effective dose for you.
For both medications, patients typically find that the starting dose is effective for them, and they continue with this dose until they reach their goal.
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist, which means it mimics a hormone called GLP-1 that we produce naturally. It promotes satiety (fullness), slows gastric emptying, and increases glucose-dependent insulin release for regulation of blood glucose.
Tirzepatide includes a GLP-1 receptor agonist as well as a GIP agonist, so it combats hunger from two angles. Over the course of a year, patients may lose more weight overall than with semaglutide, and deal with less side effects, especially nausea.
Didn't find the answer?
Please, call our customer service or get an appointment with our doctor